Uterine Fibroids: Crowdfunding Campaign to Complete Technology Development

A women-led medical device company has announced the launch of a crowdfunding campaign aimed at raising additional funds to develop its … continue reading “Uterine Fibroids: Crowdfunding Campaign to Complete Technology Development”

Covidien Showcases New Gizmos At 2012 American College of Surgeons Clinical Congress

Covidien is showcasing some of its most innovative surgical products at the American College of Surgeons (ACS) annual clinical congress being held at McCormick Place in Chicago this week. Key featured products include the new Sonicision™ ultrasonic incision and hemostasis device as well as the company’s iDrive™ Ultra powered stapling system.

Deep Brain Stimulation Advances With EU Launch of Boston Sci’s Vercise™ DBS System

Boston Scientific Corporation has received CE Mark approval for use of its Vercise™ Deep Brain Stimulation System for the treatment of Parkinson’s disease. The company says this is the first and only commercially available DBS system to incorporate multiple independent current control, which is designed to selectively stimulate targeted areas in the brain.

New Stentys Self-Apposing® Coronary Stent-Delivery System Facilitates Implantation in More Complex Vessel Anatomies

Stentys is a French-headquartered medical technology company commercialising the world’s first and only self-apposing stent to treat Acute Myocardial Infarction (AMI). The company has announced the European commercial release of an enhanced stent-delivery system for its Self-Apposing® stent. The change involves use of a new catheter to implant the stent, which has a hydrophilic coating and an ergonomic handle that considerably facilitates stent implantation in tortuous vessels.

NeuroSigma’s Monarch eTNS System to be Unveiled in London

NeuroSigma, Inc., a Los Angeles-based medical device company, announced today that its Monarch™ eTNS™ system for the adjunctive treatment of epilepsy and depression will make its debut at the 10th European Congress on Epileptology, which takes place in London, England from September 30 to October 4, 2012.